Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001140361-25-019149
Filing Date
2025-05-15
Accepted
2025-05-15 07:50:33
Documents
72
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q ef20047558_10q.htm   iXBRL 10-Q 794396
7 EXHIBIT 31.1 ef20047558_ex31-1.htm EX-31.1 10873
8 EXHIBIT 31.2 ef20047558_ex31-2.htm EX-31.2 11020
9 EXHIBIT 32.1 ef20047558_ex32-1.htm EX-32.1 5547
10 EXHIBIT 32.2 ef20047558_ex32-2.htm EX-32.2 5549
  Complete submission text file 0001140361-25-019149.txt   5223957

Data Files

Seq Description Document Type Size
2 INLINE XBRL TAXONOMY EXTENSION - SCHEMA galt-20250331.xsd EX-101.SCH 46123
3 INLINE XBRL TAXONOMY EXTENSION - DEFINITION LINKBASE galt-20250331_def.xml EX-101.DEF 260217
4 INLINE XBRL TAXONOMY EXTENSION - LABEL LINKBASE galt-20250331_lab.xml EX-101.LAB 424491
5 INLINE XBRL TAXONOMY EXTENSION - PRESENTATION LINKBASE galt-20250331_pre.xml EX-101.PRE 270613
6 INLINE XBRL TAXONOMY EXTENSION - CALCULATION LINKBASE DOCUMENT galt-20250331_cal.xml EX-101.CAL 29306
75 EXTRACTED XBRL INSTANCE DOCUMENT ef20047558_10q_htm.xml XML 592460
Mailing Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071
Business Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071 678-620-3186
GALECTIN THERAPEUTICS INC (Filer) CIK: 0001133416 (see all company filings)

EIN.: 043562325 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31791 | Film No.: 25948763
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)